James D. Chalmers, MBChB, PhD
Advertisement
James Chalmers, MBChB, PhD, is Asthma and Lung UK Chair of Respiratory Medicine at the School of Medicine, University of Dundee.
Articles by James D. Chalmers, MBChB, PhD
This interview highlights the subgroup analysis findings of the ASPEN trial, specifically on brensocatib for non-cystic fibrosis bronchiectasis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5